As the rapid expansion of biologics continues, today’s high‑concentration injectables, prefilled syringes and cartridges, as ...

Forward-thinking CDMOs are redefining collaboration by helping brand owners translate consumer insight into differentiated, ...

Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous ...

From quality-led differentiation to digital alignment and regional strategy, CDMOs are redefining how they compete in a more ...